Abstract
This study evaluated the initial feasibility and safety of reduced-port robotic cholecystectomy using the Revo-i robotic system (meerecompany Inc.) in nine patients diagnosed with symptomatic gallstones and chronic cholecystitis. All surgeries were successfully completed without complications or conversion to conventional methods. Postoperative outcomes were excellent, with minimal pain immediately after surgery, significantly reduced by the next day. Most patients were discharged on postoperative day one. Cosmetic outcomes were outstanding, with barely noticeable scars at the umbilical and flank port sites. These findings demonstrate that Revo-i robotic cholecystectomy is technically feasible, safe, and patient-friendly, suggesting potential for broader application in hepatobiliary and pancreatic surgeries.